These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16340649)

  • 1. Functional magnetic resonance and spectroscopy in drug and substance abuse.
    Magalhaes AC
    Top Magn Reson Imaging; 2005 Jun; 16(3):247-51. PubMed ID: 16340649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature.
    Hellem T; Shi X; Latendresse G; Renshaw PF
    J Am Psychiatr Nurses Assoc; 2015; 21(4):244-75. PubMed ID: 26282670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
    Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
    Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecstasy in the brain: a model for neuroimaging.
    Hurley RA; Reneman L; Taber KH
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):125-9. PubMed ID: 11983786
    [No Abstract]   [Full Text] [Related]  

  • 5. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
    Chang L; Ernst T; Speck O; Grob CS
    Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging and spectroscopy of regional brain structure in a 10-year-old boy with elevated blood lead levels.
    Trope I; Lopez-Villegas D; Lenkinski RE
    Pediatrics; 1998 Jun; 101(6):E7. PubMed ID: 9606249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal cerebral metabolism in polydrug abusers during early withdrawal: a 31P MR spectroscopy study.
    Christensen JD; Kaufman MJ; Levin JM; Mendelson JH; Holman BL; Cohen BM; Renshaw PF
    Magn Reson Med; 1996 May; 35(5):658-63. PubMed ID: 8722816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse.
    O'Neill J; Cardenas VA; Meyerhoff DJ
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1673-82. PubMed ID: 11707642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study.
    Ernst T; Chang L; Leonido-Yee M; Speck O
    Neurology; 2000 Mar; 54(6):1344-9. PubMed ID: 10746608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.
    Licata SC; Renshaw PF
    Ann N Y Acad Sci; 2010 Feb; 1187():148-71. PubMed ID: 20201852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
    Lyoo IK; Kong SW; Sung SM; Hirashima F; Parow A; Hennen J; Cohen BM; Renshaw PF
    Psychiatry Res; 2003 Jun; 123(2):87-100. PubMed ID: 12850248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysubstance and alcohol dependence: unique abnormalities of magnetic resonance-derived brain metabolite levels.
    Abé C; Mon A; Durazzo TC; Pennington DL; Schmidt TP; Meyerhoff DJ
    Drug Alcohol Depend; 2013 Jun; 130(1-3):30-7. PubMed ID: 23122599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging and magnetic resonance spectroscopy assessment of brain function in experimental animals and man.
    Morris PG
    J Psychopharmacol; 1999 Dec; 13(4):330-6. PubMed ID: 10667608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
    Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
    Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging in drug and substance abuse part II: opioids and solvents.
    Borne J; Riascos R; Cuellar H; Vargas D; Rojas R
    Top Magn Reson Imaging; 2005 Jun; 16(3):239-45. PubMed ID: 16340648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?
    Vion-Dury J; Meyerhoff DJ; Cozzone PJ; Weiner MW
    J Neurol; 1994 May; 241(6):354-71. PubMed ID: 7931430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-voxel proton MR spectroscopy in toluene abuse.
    Aydin K; Sencer S; Ogel K; Genchellac H; Demir T; Minareci O
    Magn Reson Imaging; 2003 Sep; 21(7):777-85. PubMed ID: 14559343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal cocaine exposure, illicit-substance use and stress and craving processes during adolescence.
    Yip SW; Lacadie CM; Sinha R; Mayes LC; Potenza MN
    Drug Alcohol Depend; 2016 Jan; 158():76-85. PubMed ID: 26627911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
    J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor structural brain changes in young drug abusers. A magnetic resonance study.
    Aasly J; Storsaeter O; Nilsen G; Smevik O; Rinck P
    Acta Neurol Scand; 1993 Mar; 87(3):210-4. PubMed ID: 8475692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.